公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2003 | Baicalein and baicalin are potent inhibitors of angiogenesis: Inhibition of endothelial cell proliferation, migration and differentiation | Liu J.-J.; TIEN-SHANG HUANG ; WEN-FANG CHENG ; Lu F.-J. | International Journal of Cancer | 128 | 116 | |
2019 | Bevacizumab dose affects the severity of adverse events in gynecologic malignancies | Lee S.-P.; HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Frontiers in Pharmacology | 15 | 17 | |
2019 | Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization | Sun N.-Y.; YU-LI CHEN ; Wu W.-Y.; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancers | 39 | 38 | |
2011 | Brain metastasis as a late manifestation of ovarian carcinoma | YU-LI CHEN ; WEN-FANG CHENG ; CHANG-YAO HSIEH ; CHI-AN CHEN | European Journal of Cancer Care | 24 | 18 | |
2019 | BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes | YU-LI CHEN ; Lin H.-W.; CHUNG-LIANG CHIEN ; YEN-LING LAI ; WEI-ZEN SUN ; CHI-AN CHEN ; WEN-FANG CHENG | Journal for ImmunoTherapy of Cancer | 66 | 48 | |
2001 | Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen | Hung C.-F.; WEN-FANG CHENG ; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C. | Cancer Research | 0 | | |
2002 | Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion | WEN-FANG CHENG ; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C. | Human Gene Therapy | 115 | 103 | |
2003 | CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination | WEN-FANG CHENG ; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C. | Gene Therapy | 55 | 49 | |
2018 | CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer | Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU ; Lin, Hsiu-Ping; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Epigenomics | 10 | 9 | |
2014 | Cell-type-dependent associations of heme oxygenase-1 GT-repeat polymorphisms with the cancer risk in arsenic-exposed individuals: A preliminary report | Wu M.M.; WEN-FANG CHENG ; Hsu L.-I.; Chen C.-J.; Chiou H.-Y.; Lee T.C. | One Century of the Discovery of Arsenicosis in Latin America (1914-2014): As 2014 - Proceedings of the 5th International Congress on Arsenic in the Environment | 0 | | |
1999 | Cervical pregnancy: Assessment with three-dimensional power Doppler imaging and successful management with selective uterine artery embolization | Su Y.-N.; JIN-CHUNG SHIH ; Chiu W.-H.; CHIEN-NAN LEE ; WEN-FANG CHENG ; FON-JOU HSIEH | Ultrasound in Obstetrics and Gynecology | 35 | 17 | |
2005 | Characterization of DNA vaccines encoding the domains of calreticulin for their ability to elicit tumor-specific immunity and antiangiogenesis | WEN-FANG CHENG ; Hung C.-F.; CHI-AN CHEN ; CHIEN-NAN LEE ; Su Y.-N.; Chai C.-Y.; Boyd D.A.K.; CHANG-YAO HSIEH ; Wu T.-C. | Vaccine | 27 | 24 | |
2021 | Chemotherapeutic Regimens and Chemotherapy-Free Intervals Influence the Survival of Patients with Recurrent Advanced Epithelial Ovarian Carcinoma: A Retrospective Population-Based Study | Huang, Hsin-Ying; CHUN-JU CHIANG ; Chen, Yun-Yuan; You, San-Lin; HENG-CHENG HSU ; Tang, Chao-Hsiun; WEN-FANG CHENG | International journal of environmental research and public health | 2 | 3 | |
2019 | CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells | Lin H.-W.; YING-CHENG CHIANG ; Sun N.-Y.; YU-LI CHEN ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 12 | 13 | |
2006 | Chimeric DNA vaccine reverses morphine-induced immunosuppression and tumorigenesis | WEN-FANG CHENG ; LI-KUEI CHEN ; CHI-AN CHEN ; Chang M.-C.; PO-NI HSIAO ; Su Y.-N.; CHIEN-NAN LEE ; Jeng H.-J.; CHANG-YAO HSIEH ; WEI-ZEN SUN | Molecular Therapy | 22 | 18 | |
2014 | Circulating IGF system and treatment outcome in epithelial ovarian cancer | Huang Y.-F.; WEN-FANG CHENG ; Wu Y.-P.; Cheng Y.-M.; Hsu K.-F.; Chou C.-Y. | Endocrine-Related Cancer | 39 | 36 | |
2007 | Clear cell adenocarcinoma of the uterine cervix [9] | Chen C.-W.; Hsiao H.-M.; CHI-AN CHEN ; CHANG-YAO HSIEH ; WEN-FANG CHENG | Taiwanese Journal of Obstetrics and Gynecology | 5 | 0 | |
2019 | Clear cell carcinoma of the abdominal wall as a rare complication of general obstetric and gynecologic surgeries: 15 years of experience at a large academic institution | YEN-LING LAI ; HENG-CHENG HSU ; KUAN-TING KUO ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | International Journal of Environmental Research and Public Health | 15 | 10 | |
1998 | Clinical application of intratumoral blood flow study in patients with endometrial carcinoma | WEN-FANG CHENG ; Chen, Tzer-Ming; CHI-AN CHEN ; CHIH-CHENG WU ; Huang, Kuang-Ta; CHANG-YAO HSIEH ; FON-JOU HSIEH | Cancer | 38 | | |
2024 | Clinical characteristics and treatment modalities in women with newly diagnosed advanced high-grade serous epithelial ovarian cancer in Taiwan | HENG-CHENG HSU ; Chou, Hung-Hsueh; WEN-FANG CHENG ; Chang, Chih-Long | Journal of the Formosan Medical Association = Taiwan yi zhi | | | |